Cheng Jonathan H, Hoofnagle Andrew N, Katz Ronit, Kritchevsky Stephen B, Shlipak Michael G, Sarnak Mark J, Ix Joachim H, Ginsberg Charles
Division of Nephrology-Hypertension University of California San Diego CA USA.
Nephrology Section Veterans Affairs San Diego Healthcare System San Diego CA USA.
JBMR Plus. 2023 Jun 13;7(9):e10781. doi: 10.1002/jbm4.10781. eCollection 2023 Sep.
Vitamin D deficiency is prevalent in 25% of Americans. However, 25(OH)D may not be an accurate measure of vitamin D because the majority (85%-90%) of 25(OH)D is bound to vitamin D binding protein (VDBP), which varies by over 30% across individuals. Free 25(OH)D may be a better measure, but it is difficult to measure accurately and precisely. The existing free 25(OH)D estimating equation does not include VDBP phenotypes; therefore, new equations that include this variable may be more accurate. A total of 370 participants in the Health, Aging, and Body Composition Study, a cohort of healthy community-dwelling individuals aged 70-79 years old, underwent VDBP and vitamin D metabolite [25(OH)D, 24,25(OH)D, 1,25(OH)D, free 25(OH)D] measurements and were randomly allocated into equation development (two out of three) and internal validation (one out of three) groups. New equations were developed with multiple linear regression and were internally validated with Bland-Altman plots. The mean age was 75 ± 3 years, 53% were female, and the mean measured free 25(OH)D was 5.37 ± 1.81 pg/mL. Three equations were developed. The first equation included albumin, 25(OH)D, 25(OH)D, VDBP, 1,25(OH)D, and 24,25(OH)D. The second equation included all variables in Eq. (1) plus VDBP phenotypes. The third equation included albumin, 25(OH)D, intact parathyroid hormone, and 1,25(OH)D. In internal validation, all three new equations predicted free 25(OH)D values within 30% and 15% of the measured free 25(OH)D concentrations in 76%-80% and 48%-52% of study participants, respectively. Equation (2) was the most precise, with a mean bias of 0.06 (95% limits of agreement -2.41 to 2.30) pg/mL. The existing equation estimated free 25(OH)D within 30% and 15% of measured free 25(OH)D in 43% and 22% of participants, respectively. Free 25(OH)D can be estimated with clinically available biomarkers as well as with more laboratory-intensive biomarkers with moderate precision. © 2023 The Authors. published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
25%的美国人存在维生素D缺乏的情况。然而,25(OH)D可能并非维生素D的准确衡量指标,因为大部分(85%-90%)的25(OH)D与维生素D结合蛋白(VDBP)结合,而VDBP在个体间的差异超过30%。游离25(OH)D可能是更好的衡量指标,但难以准确精确地测量。现有的游离25(OH)D估算方程未纳入VDBP表型;因此,纳入该变量的新方程可能更准确。健康、衰老与身体成分研究共有370名参与者,他们是年龄在70-79岁的健康社区居民队列,接受了VDBP和维生素D代谢物[25(OH)D、24,25(OH)D、1,25(OH)D、游离25(OH)D]的测量,并被随机分为方程开发组(三分之二)和内部验证组(三分之一)。通过多元线性回归开发新方程,并使用Bland-Altman图进行内部验证。平均年龄为75±3岁,53%为女性,测得的游离25(OH)D平均水平为5.37±1.81 pg/mL。开发了三个方程。第一个方程纳入了白蛋白、25(OH)D、25(OH)D、VDBP、1,25(OH)D和24,25(OH)D。第二个方程纳入了方程(1)中的所有变量以及VDBP表型。第三个方程纳入了白蛋白、25(OH)D、完整甲状旁腺激素和1,25(OH)D。在内部验证中,所有三个新方程在分别76%-80%和48%-52%的研究参与者中预测的游离25(OH)D值在测量的游离25(OH)D浓度的30%和15%以内。方程(2)最精确,平均偏差为0.06(95%一致性界限为-2.41至2.30)pg/mL。现有方程在分别43%和22%的参与者中预测的游离25(OH)D在测量的游离25(OH)D的30%和15%以内。游离25(OH)D可以通过临床可用的生物标志物以及更多需要大量实验室检测的生物标志物以适度的精度进行估算。© 2023作者。由Wiley Periodicals LLC代表美国骨与矿物质研究学会出版。